These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6734467)

  • 1. Effects of drug and chemical pretreatments on biliary excretion of phenylcyclohexene in the rat.
    Law FC; Chakrabarti S
    Drug Chem Toxicol; 1984; 7(3):273-82. PubMed ID: 6734467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inducers and inhibitors of mixed-function oxidases on the biliary excretion of pentacaine metabolites.
    Kukan M; Bezek S; Scasnár V; Durisová M; Trnovec T
    Biopharm Drug Dispos; 1990 Jul; 11(5):395-401. PubMed ID: 2207293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary excretion of 3-methylcholanthrene as controlled by its metabolism.
    Levine WG
    J Pharmacol Exp Ther; 1972 Nov; 183(2):420-6. PubMed ID: 5083554
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic uptake, metabolism, and biliary excretion of 7,12-dimethylbenzanthracene in the rat.
    Levine WG
    Drug Metab Dispos; 1974; 2(2):169-77. PubMed ID: 4150997
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction and inhibition of the metabolism and biliary excretion of the azo dye carcinogen, N,N-dimethyl-4-aminoazobenzene (DAB), in the rat.
    Levine WG
    Drug Metab Dispos; 1980; 8(4):212-7. PubMed ID: 6105053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromobenzene-glutathione excretion into bile reflects toxic activation of bromobenzene in rats.
    Madhu C; Klaassen CD
    Toxicol Lett; 1992 Apr; 60(2):227-36. PubMed ID: 1570637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inducers and inhibitors of cytochrome P-450-linked monooxygenases on the toxicity, in vitro metabolism and in vivo irreversible binding of 2-methylnaphthalene in mice.
    Griffin KA; Johnson CB; Breger RK; Franklin RB
    J Pharmacol Exp Ther; 1982 Jun; 221(3):517-24. PubMed ID: 7086669
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical modulation of 1,2-dibromo-3-chloropropane toxicity.
    Kluwe WM
    Toxicology; 1983; 27(3-4):287-99. PubMed ID: 6623477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of secalonic acid D with phenobarbital, 3-methyl cholanthrene, and SKF-525A in mice.
    Reddy CS; Reddy RV; Hayes AW
    J Toxicol Environ Health; 1983; 12(4-6):687-94. PubMed ID: 6668617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the in vivo metabolism of hydralazine in the rat.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):184-9. PubMed ID: 6135573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mixed function oxidase (MFO) in the metabolism of the spin trapping agent alpha-phenyl-N-tert-butyl-nitrone (PBN) in rats.
    Chen GM; Bray TM; Janzen EG; McCay PB
    Free Radic Res Commun; 1991; 14(1):9-16. PubMed ID: 2022348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of various pretreatments on the acute nephrotoxic potential of styrene in Fischer-344 rats.
    Chakrabarti SK; Tuchweber B
    Toxicology; 1987 Nov; 46(3):343-56. PubMed ID: 3672539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenated aromatic hydrocarbons.
    Reid WD; Krishna G
    Exp Mol Pathol; 1973 Feb; 18(1):80-99. PubMed ID: 4693627
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of some hepatic enzyme inducers and inhibitors on extrahepatic drug metabolism.
    Lake BG; Hopkins R; Chakraborty J; Bridges JW; Parke DV
    Drug Metab Dispos; 1973; 1(1):342-9. PubMed ID: 4149403
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
    Buckpitt AR; Bahnson LS; Franklin RB
    J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary excretion of N,N-dimethyl-4-aminoazobenzene (DAB) in the rat. Effects of pretreatment with inducers and inhibitors of the mixed-function oxidase system and with agents that deplete liver glutathione.
    Levine WG; Finkelstein TT
    Drug Metab Dispos; 1978; 6(3):265-72. PubMed ID: 26547
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in tissue distribution of chlordecone (kepone) in the rat following phenobarbital or SKF-525A administration.
    Aldous CN; Chetty CS; Desaiah D
    J Toxicol Environ Health; 1983 Mar; 11(3):365-72. PubMed ID: 6188850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
    Gregus Z; Madhu C; Klaassen CD
    Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mixed-function oxidases and non-protein sulfhydryl content in [14C]-2-chloro-4-acetotoluidide binding to liver and kidney in starlings.
    Giri SN; Siegel DM
    J Appl Toxicol; 1990 Dec; 10(6):429-38. PubMed ID: 2084182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic glutathione and hepatotoxicity: effects of cytochrome P-450 complexing compounds SKF 525-A, L-alpha acetylmethadol (LAAM), norLAAM, and piperonyl butoxide.
    James RC; Harbison RD
    Biochem Pharmacol; 1982 May; 31(10):1829-35. PubMed ID: 7104014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.